Drug: Epirubicin Injury: Disease progression Quarter: 2016Q3
Total Records: 10 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
104219112 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160825 | IT | |
125562881 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
125563971 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
125564011 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
125564421 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
125564591 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
125565381 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
126748771 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160823 | CN | |
126825121 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160825 | CN | |
127328461 | Epirubicin | Disease progression | CIPLA | 0.00 | 0 | 20160912 | ZA |
Total Records: 10 Number of Pages: 1